Atrial fibrillation: verapamil slowed the ventricular rate.
|
|
|
Clinical bottom line (level 1b)
-
Patients with atrial fibrillation or flutter poorly-controlled by digoxin who received verapamil iv compared with placebo were more likely to go into sinus rhythm
(NNT =
3
at 10
minutes)
.
-
Patients had a lower ventricular rate (on average 37 beats/min less).
|
|
Tommaso et al:
Archives of Internal Medicine
1983;
143:
877-881
|
Expires
November 2004
|
The study
Double-blinded concealed randomised
trial
with
intention-to-treat
Setting: university hospital, USA
17 patients
(aged
?,
?%
male)
atrial fibrillation or flutter poorly controlled by digitalis with or without disopyramide, quinidine or lidocaine (resting heart rate >110 beats/min)
Excluded if
on beta-blockers within last 48 hours
sick sinus syndrome (unless a pacemaker in situ)
second degree or higher AV block
MI within last 3 months
Control Group: (n = 9, 9 analysed):
placebo
Experimental Group: (n = 8, 8 analysed):
verapamil
0.075 mg/kg iv over 60 seconds (to a maximum of 5 mg)
100% followed for
10
minutes
The evidence
| Outcome |
Time to outcome |
CER | EER | RRR (95% CI) | ARR (95% CI) | NNT (95% CI) |
| no sinus rhythm
|
10
minutes |
9 (100%) |
5 (62.5%) |
38% (-7% to
63%) |
37.5% (3.95% to
71.1%) |
3
(1 to
25)
|
| Outcome |
Control Group (SD) |
Experimental Group (SD) |
Mean Difference (95% CI) |
| ventricular rate at start
|
120
(9)
|
127
(13)
|
7
(-4 to 18)
|
| ventricular rate at 10 minutes
|
123
(9)
|
86
(14)
|
-37
(-49 to -25)
|
Citation
-
Tommaso
C,
McDonough
T,
Parker
M, et al:
Atrial fibrillation and flutter: immediate control and conversion with intravenously administered verapamil.
Archives of Internal Medicine
1983;
143:
877-881
Contributor: Chris Ball and Clare Wotton,
November 2000
Reviewer:
Clinical Question.
| Patient |
AF |
| Intervention or Exposure |
verapamil |
| Comparison |
placebo |
| Outcome |
reversion to sinus rhythm |
|
|